F Dx Advisors, Inc. Genmab A/S Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$35.27 - $42.24 $247,136 - $295,975	7,007 New	7,007 $247,000
Q4 2022 Feb 09, 2023	SELL	$33.8 - $47.06 $98,019 - $136,474	-2,900 Reduced 20.9%	10,976 $465,000
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $87,404 - $1.04 Million	2,773 Added 24.98%	13,876 $446,000
Q2 2022 Aug 03, 2022	SELL	$26.83 - $38.57 $509,340 - $732,212	-18,984 Reduced 63.1%	11,103 $361,000
Q1 2022 May 03, 2022	BUY	$30.95 - $39.68 $79,851 - $102,374	2,580 Added 9.38%	30,087 $1.09 Million
Q4 2021 Feb 01, 2022	BUY	$35.87 - $47.12 $25,682 - $33,737	716 Added 2.67%	27,507 $1.09 Million
Q3 2021 Oct 08, 2021	SELL	$41.55 - $48.72 $77,075 - $90,375	-1,855 Reduced 6.48%	26,791 $1.17 Million
Q2 2021 Aug 05, 2021	SELL	$32.88 - $44.57 $5,786 - $7,844	-176 Reduced 0.61%	28,646 $1.17 Million
Q1 2021 Apr 14, 2021	BUY	$30.92 - $44.4 $861,925 - $1.24 Million	27,876 Added 2946.72%	28,822 $946,000
Q1 2021 Apr 13, 2021	SELL	$30.92 - $44.4 $842,260 - $1.21 Million	-27,240 Reduced 96.64%	946 $31,000
Q4 2020 Feb 08, 2021	BUY	$33.66 - $40.76 $6,866 - $8,315	204 Added 0.73%	28,186 $1.15 Million
Q3 2020 Nov 12, 2020	SELL	$33.07 - $38.68 $132,610 - $155,106	-4,010 Reduced 12.53%	27,982 $1.02 Million
Q2 2020 Jul 22, 2020	SELL	$20.05 - $33.89 $125,994 - $212,964	-6,284 Reduced 16.42%	31,992 $1.08 Million
Q1 2020 May 22, 2020	BUY	$17.15 - $25.22 $656,433 - $965,320	38,276 New	38,276 $811,000
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $602,205 - $885,575	-35,114 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$18.88 - $24.14 $11,818 - $15,111	-626 Reduced 1.75%	35,114 $784,000
Q3 2019 Nov 07, 2019	BUY	$18.0 - $21.38 $643,320 - $764,121	35,740 New	35,740 $724,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account